Table 1 Characteristics of participants enrolled in the study
Characteristics | Total | Cases (n = 66) n (%) | Controls (n = 132) n (%) | P-Value§ |
|---|---|---|---|---|
Sex | 0.98 | |||
Male | 120 (60.6) | 40 (60.6) | 80 (60.6) | |
Female | 78 (39.4) | 26 (39.4) | 52 (39.4) | |
Age | 0.09 | |||
0–18 | 9 (4.6) | 1 (1.52) | 8 (6.1) | |
19–34 | 91 (46.0) | 32 (48.5) | 59 (44.7) | |
35–49 | 74 (37.4) | 21 (31.8) | 53 (40.2) | |
50+ | 24 (12.0) | 12 (18.2) | 12 (9.1) | |
Education | 0.02 | |||
None | 56 (28.3) | 24 (36.4) | 32 (24.2) | |
Primary | 78 (39.4) | 28 (42.4) | 50 (37.9) | |
Secondary & above | 64 (32.3) | 14 (21.2) | 50 (37.9) | |
Occupation | 0.51 | |||
Unskilled work | 166 (83.8) | 57 (86.4) | 109 (82.6) | |
Skilled work | 32 (16.2) | 9 (13.6) | 23 (17.4) | |
Previous history of TB¶ | 0.80 | |||
Yes | 108 (55.1) | 35 (53.8) | 73 (55.7) | |
No | 88 (44.9) | 30 (46.2) | 58 (44.3) | |
HIV Status¶ | 0.04 | |||
Positive | 118 (59.6) | 45 (70.3) | 73 (55.3) | |
Negative | 78 (40.4) | 19 (29.7) | 59 (44.7) | |
CD4 Count¶ | 0.48 | |||
< 200 | 28 (71.8) | 11 (78.6) | 17 (68.0) | |
≥ 200 | 11 (28.2) | 3 (21.4) | 8 (32.0) | |
Adherence to ART | 0.99 | |||
Good | 195 (98.5) | 65 (98.5) | 130 (98.5) | |
Poor | 3 (1.5) | 1 (1.5) | 2 (1.5) | |
Documented medical complicationb | ||||
Yes | 102 (51.5) | 39 (59.1) | 63 (47.7) | 0.03 |
No | 96 (48.5) | 27 (40.9) | 69 (52.3) | |
Missed DR-TB dosesa | ||||
Yes | 126 (63.6) | 38 (57.6) | 88 (66.7) | 0.01 |
No | 72 (36.4) | 28 (42.4) | 44 (33.3) | |
Type of health facility for follow-up care | ||||
MDR-TB treatment site | 111 (56.1) | 27 (40.9) | 84 (63.6) | |
Primary care health facility | 87 (43.9) | 39 (59.1) | 48 (36.4) | 0.71 |